Outpatient clinical activities are located at the Great Lakes Cancer Institute at Ingham Regional Medical Center, an affiliate of McLaren Healthcare Corporation. In-patients are hospitalized in special oncology units staffed by oncology nurses, clinical pharmacists, physicians and occupational therapists. In addition, statewide hemophilia clinics are available in the spring, summer, and fall for interested subspecialty residents.
Hematology/Oncology Fellowship Program at Michigan State University
offers multiple opportunities for clinical and research experience.
Michigan State University is a member of the National Surgical
Adjuvant Breast and Bowel Project (NSABP), the Southwest Oncology Group
(SWOG) and the MSU Cancer Treatment Consortium (MSU CTC), a clinical
trial consortium composed of practicing Michigan oncologists. These
groups offer opportunities for participation in clinical oncology protocols.
Multiple opportunities exist for training in basic sciences with research in the fields of carcinogenesis, cancer pharmacology, tumor biology, tumor immunology and other oncologically related areas. Hematology research areas include clinical hemophilia, biochemistry of humoral clotting factors, platelet immunology, iron overload, immunology of tissue compatibility and other areas.
Applicants must successfully complete an Internal Medicine residency program in the United States before they are eligible to apply for a subspecialty fellowship.
For additional information, please contact either Anas Al-Janadi, MD, Program Director or Becky McMahon, Program Coordinator at (517) 353-4811, e-mail Becky.McMahon@ht.msu.edu